nodes	percent_of_prediction	percent_of_DWPC	metapath
Eszopiclone—CYP3A4—bone cancer	0.75	1	CbGaD
Eszopiclone—Zopiclone—CYP3A4—bone cancer	0.00556	1	CrCbGaD
Eszopiclone—Ataxia—Epirubicin—bone cancer	0.000471	0.00193	CcSEcCtD
Eszopiclone—Tachycardia—Cisplatin—bone cancer	0.000468	0.00192	CcSEcCtD
Eszopiclone—Dehydration—Epirubicin—bone cancer	0.000466	0.00191	CcSEcCtD
Eszopiclone—Osteoarthritis—Doxorubicin—bone cancer	0.000464	0.0019	CcSEcCtD
Eszopiclone—Diplopia—Doxorubicin—bone cancer	0.000464	0.0019	CcSEcCtD
Eszopiclone—Hyperhidrosis—Cisplatin—bone cancer	0.000464	0.0019	CcSEcCtD
Eszopiclone—Asthma—Methotrexate—bone cancer	0.000463	0.00189	CcSEcCtD
Eszopiclone—Dry skin—Epirubicin—bone cancer	0.000459	0.00188	CcSEcCtD
Eszopiclone—Anorexia—Cisplatin—bone cancer	0.000457	0.00187	CcSEcCtD
Eszopiclone—Migraine—Doxorubicin—bone cancer	0.000457	0.00187	CcSEcCtD
Eszopiclone—Affect lability—Doxorubicin—bone cancer	0.000457	0.00187	CcSEcCtD
Eszopiclone—Hypokalaemia—Epirubicin—bone cancer	0.000456	0.00187	CcSEcCtD
Eszopiclone—Aspartate aminotransferase increased—Epirubicin—bone cancer	0.000451	0.00185	CcSEcCtD
Eszopiclone—Face oedema—Doxorubicin—bone cancer	0.000448	0.00183	CcSEcCtD
Eszopiclone—Gastritis—Epirubicin—bone cancer	0.000444	0.00182	CcSEcCtD
Eszopiclone—Muscular weakness—Epirubicin—bone cancer	0.000442	0.00181	CcSEcCtD
Eszopiclone—Mood swings—Doxorubicin—bone cancer	0.000439	0.0018	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000437	0.00179	CcSEcCtD
Eszopiclone—Ataxia—Doxorubicin—bone cancer	0.000436	0.00179	CcSEcCtD
Eszopiclone—Influenza—Epirubicin—bone cancer	0.000433	0.00177	CcSEcCtD
Eszopiclone—Dysphagia—Epirubicin—bone cancer	0.000433	0.00177	CcSEcCtD
Eszopiclone—Asthma—Epirubicin—bone cancer	0.000433	0.00177	CcSEcCtD
Eszopiclone—Dysuria—Methotrexate—bone cancer	0.000433	0.00177	CcSEcCtD
Eszopiclone—Dehydration—Doxorubicin—bone cancer	0.000431	0.00177	CcSEcCtD
Eszopiclone—Paraesthesia—Cisplatin—bone cancer	0.000431	0.00176	CcSEcCtD
Eszopiclone—Dyspnoea—Cisplatin—bone cancer	0.000428	0.00175	CcSEcCtD
Eszopiclone—Erectile dysfunction—Methotrexate—bone cancer	0.000426	0.00175	CcSEcCtD
Eszopiclone—Dry skin—Doxorubicin—bone cancer	0.000425	0.00174	CcSEcCtD
Eszopiclone—Photosensitivity reaction—Methotrexate—bone cancer	0.000423	0.00173	CcSEcCtD
Eszopiclone—Hypokalaemia—Doxorubicin—bone cancer	0.000422	0.00173	CcSEcCtD
Eszopiclone—Aspartate aminotransferase increased—Doxorubicin—bone cancer	0.000418	0.00171	CcSEcCtD
Eszopiclone—Decreased appetite—Cisplatin—bone cancer	0.000417	0.00171	CcSEcCtD
Eszopiclone—Bronchitis—Epirubicin—bone cancer	0.000417	0.00171	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Cisplatin—bone cancer	0.000414	0.0017	CcSEcCtD
Eszopiclone—Drowsiness—Methotrexate—bone cancer	0.000413	0.00169	CcSEcCtD
Eszopiclone—Depression—Methotrexate—bone cancer	0.000412	0.00168	CcSEcCtD
Eszopiclone—Gastritis—Doxorubicin—bone cancer	0.00041	0.00168	CcSEcCtD
Eszopiclone—Pain—Cisplatin—bone cancer	0.00041	0.00168	CcSEcCtD
Eszopiclone—Muscular weakness—Doxorubicin—bone cancer	0.000409	0.00167	CcSEcCtD
Eszopiclone—Dysuria—Epirubicin—bone cancer	0.000405	0.00166	CcSEcCtD
Eszopiclone—Stomatitis—Methotrexate—bone cancer	0.000402	0.00165	CcSEcCtD
Eszopiclone—Conjunctivitis—Methotrexate—bone cancer	0.000401	0.00164	CcSEcCtD
Eszopiclone—Asthma—Doxorubicin—bone cancer	0.000401	0.00164	CcSEcCtD
Eszopiclone—Dysphagia—Doxorubicin—bone cancer	0.000401	0.00164	CcSEcCtD
Eszopiclone—Influenza—Doxorubicin—bone cancer	0.000401	0.00164	CcSEcCtD
Eszopiclone—Pollakiuria—Epirubicin—bone cancer	0.0004	0.00164	CcSEcCtD
Eszopiclone—Sweating—Methotrexate—bone cancer	0.000396	0.00162	CcSEcCtD
Eszopiclone—Photosensitivity reaction—Epirubicin—bone cancer	0.000395	0.00162	CcSEcCtD
Eszopiclone—Feeling abnormal—Cisplatin—bone cancer	0.000395	0.00162	CcSEcCtD
Eszopiclone—Weight increased—Epirubicin—bone cancer	0.000394	0.00161	CcSEcCtD
Eszopiclone—Haematuria—Methotrexate—bone cancer	0.000394	0.00161	CcSEcCtD
Eszopiclone—Weight decreased—Epirubicin—bone cancer	0.000392	0.0016	CcSEcCtD
Eszopiclone—Epistaxis—Methotrexate—bone cancer	0.000389	0.00159	CcSEcCtD
Eszopiclone—Drowsiness—Epirubicin—bone cancer	0.000386	0.00158	CcSEcCtD
Eszopiclone—Bronchitis—Doxorubicin—bone cancer	0.000386	0.00158	CcSEcCtD
Eszopiclone—Body temperature increased—Cisplatin—bone cancer	0.000379	0.00155	CcSEcCtD
Eszopiclone—Neuropathy peripheral—Epirubicin—bone cancer	0.000379	0.00155	CcSEcCtD
Eszopiclone—Stomatitis—Epirubicin—bone cancer	0.000377	0.00154	CcSEcCtD
Eszopiclone—Conjunctivitis—Epirubicin—bone cancer	0.000375	0.00154	CcSEcCtD
Eszopiclone—Urinary tract infection—Epirubicin—bone cancer	0.000375	0.00154	CcSEcCtD
Eszopiclone—Dysuria—Doxorubicin—bone cancer	0.000375	0.00153	CcSEcCtD
Eszopiclone—Hepatitis—Methotrexate—bone cancer	0.000371	0.00152	CcSEcCtD
Eszopiclone—Sweating—Epirubicin—bone cancer	0.00037	0.00152	CcSEcCtD
Eszopiclone—Pollakiuria—Doxorubicin—bone cancer	0.00037	0.00152	CcSEcCtD
Eszopiclone—Haematuria—Epirubicin—bone cancer	0.000368	0.00151	CcSEcCtD
Eszopiclone—Pharyngitis—Methotrexate—bone cancer	0.000368	0.00151	CcSEcCtD
Eszopiclone—Photosensitivity reaction—Doxorubicin—bone cancer	0.000366	0.0015	CcSEcCtD
Eszopiclone—Weight increased—Doxorubicin—bone cancer	0.000365	0.00149	CcSEcCtD
Eszopiclone—Epistaxis—Epirubicin—bone cancer	0.000364	0.00149	CcSEcCtD
Eszopiclone—Weight decreased—Doxorubicin—bone cancer	0.000363	0.00148	CcSEcCtD
Eszopiclone—Drowsiness—Doxorubicin—bone cancer	0.000357	0.00146	CcSEcCtD
Eszopiclone—Hypersensitivity—Cisplatin—bone cancer	0.000353	0.00145	CcSEcCtD
Eszopiclone—Erythema multiforme—Methotrexate—bone cancer	0.00035	0.00143	CcSEcCtD
Eszopiclone—Neuropathy peripheral—Doxorubicin—bone cancer	0.00035	0.00143	CcSEcCtD
Eszopiclone—Stomatitis—Doxorubicin—bone cancer	0.000348	0.00143	CcSEcCtD
Eszopiclone—Rhinitis—Epirubicin—bone cancer	0.000348	0.00142	CcSEcCtD
Eszopiclone—Urinary tract infection—Doxorubicin—bone cancer	0.000347	0.00142	CcSEcCtD
Eszopiclone—Conjunctivitis—Doxorubicin—bone cancer	0.000347	0.00142	CcSEcCtD
Eszopiclone—Hepatitis—Epirubicin—bone cancer	0.000347	0.00142	CcSEcCtD
Eszopiclone—Tinnitus—Methotrexate—bone cancer	0.000345	0.00141	CcSEcCtD
Eszopiclone—Hypoaesthesia—Epirubicin—bone cancer	0.000345	0.00141	CcSEcCtD
Eszopiclone—Asthenia—Cisplatin—bone cancer	0.000344	0.00141	CcSEcCtD
Eszopiclone—Pharyngitis—Epirubicin—bone cancer	0.000344	0.00141	CcSEcCtD
Eszopiclone—Sweating—Doxorubicin—bone cancer	0.000343	0.0014	CcSEcCtD
Eszopiclone—Oedema peripheral—Epirubicin—bone cancer	0.000342	0.0014	CcSEcCtD
Eszopiclone—Haematuria—Doxorubicin—bone cancer	0.000341	0.00139	CcSEcCtD
Eszopiclone—Epistaxis—Doxorubicin—bone cancer	0.000337	0.00138	CcSEcCtD
Eszopiclone—Chills—Methotrexate—bone cancer	0.000332	0.00136	CcSEcCtD
Eszopiclone—Diarrhoea—Cisplatin—bone cancer	0.000328	0.00134	CcSEcCtD
Eszopiclone—Erythema multiforme—Epirubicin—bone cancer	0.000328	0.00134	CcSEcCtD
Eszopiclone—Alopecia—Methotrexate—bone cancer	0.000327	0.00134	CcSEcCtD
Eszopiclone—Tinnitus—Epirubicin—bone cancer	0.000323	0.00132	CcSEcCtD
Eszopiclone—Rhinitis—Doxorubicin—bone cancer	0.000322	0.00132	CcSEcCtD
Eszopiclone—Hepatitis—Doxorubicin—bone cancer	0.000321	0.00131	CcSEcCtD
Eszopiclone—Hypoaesthesia—Doxorubicin—bone cancer	0.000319	0.00131	CcSEcCtD
Eszopiclone—Pharyngitis—Doxorubicin—bone cancer	0.000318	0.0013	CcSEcCtD
Eszopiclone—Oedema peripheral—Doxorubicin—bone cancer	0.000316	0.00129	CcSEcCtD
Eszopiclone—Dysgeusia—Methotrexate—bone cancer	0.000316	0.00129	CcSEcCtD
Eszopiclone—Back pain—Methotrexate—bone cancer	0.000312	0.00128	CcSEcCtD
Eszopiclone—Chills—Epirubicin—bone cancer	0.000311	0.00127	CcSEcCtD
Eszopiclone—Alopecia—Epirubicin—bone cancer	0.000306	0.00125	CcSEcCtD
Eszopiclone—Vomiting—Cisplatin—bone cancer	0.000305	0.00125	CcSEcCtD
Eszopiclone—Vision blurred—Methotrexate—bone cancer	0.000304	0.00124	CcSEcCtD
Eszopiclone—Erythema multiforme—Doxorubicin—bone cancer	0.000303	0.00124	CcSEcCtD
Eszopiclone—Rash—Cisplatin—bone cancer	0.000302	0.00124	CcSEcCtD
Eszopiclone—Dermatitis—Cisplatin—bone cancer	0.000302	0.00124	CcSEcCtD
Eszopiclone—Ill-defined disorder—Methotrexate—bone cancer	0.000299	0.00123	CcSEcCtD
Eszopiclone—Tinnitus—Doxorubicin—bone cancer	0.000299	0.00122	CcSEcCtD
Eszopiclone—Anaemia—Methotrexate—bone cancer	0.000298	0.00122	CcSEcCtD
Eszopiclone—Tension—Epirubicin—bone cancer	0.000296	0.00121	CcSEcCtD
Eszopiclone—Dysgeusia—Epirubicin—bone cancer	0.000296	0.00121	CcSEcCtD
Eszopiclone—Nervousness—Epirubicin—bone cancer	0.000293	0.0012	CcSEcCtD
Eszopiclone—Back pain—Epirubicin—bone cancer	0.000292	0.0012	CcSEcCtD
Eszopiclone—Malaise—Methotrexate—bone cancer	0.000291	0.00119	CcSEcCtD
Eszopiclone—Muscle spasms—Epirubicin—bone cancer	0.00029	0.00119	CcSEcCtD
Eszopiclone—Vertigo—Methotrexate—bone cancer	0.00029	0.00119	CcSEcCtD
Eszopiclone—Chills—Doxorubicin—bone cancer	0.000288	0.00118	CcSEcCtD
Eszopiclone—Nausea—Cisplatin—bone cancer	0.000285	0.00117	CcSEcCtD
Eszopiclone—Vision blurred—Epirubicin—bone cancer	0.000284	0.00116	CcSEcCtD
Eszopiclone—Alopecia—Doxorubicin—bone cancer	0.000284	0.00116	CcSEcCtD
Eszopiclone—Ill-defined disorder—Epirubicin—bone cancer	0.00028	0.00115	CcSEcCtD
Eszopiclone—Convulsion—Methotrexate—bone cancer	0.000279	0.00114	CcSEcCtD
Eszopiclone—Anaemia—Epirubicin—bone cancer	0.000279	0.00114	CcSEcCtD
Eszopiclone—Agitation—Epirubicin—bone cancer	0.000277	0.00114	CcSEcCtD
Eszopiclone—Chest pain—Methotrexate—bone cancer	0.000275	0.00112	CcSEcCtD
Eszopiclone—Myalgia—Methotrexate—bone cancer	0.000275	0.00112	CcSEcCtD
Eszopiclone—Tension—Doxorubicin—bone cancer	0.000274	0.00112	CcSEcCtD
Eszopiclone—Dysgeusia—Doxorubicin—bone cancer	0.000274	0.00112	CcSEcCtD
Eszopiclone—Malaise—Epirubicin—bone cancer	0.000272	0.00111	CcSEcCtD
Eszopiclone—Discomfort—Methotrexate—bone cancer	0.000271	0.00111	CcSEcCtD
Eszopiclone—Nervousness—Doxorubicin—bone cancer	0.000271	0.00111	CcSEcCtD
Eszopiclone—Vertigo—Epirubicin—bone cancer	0.000271	0.00111	CcSEcCtD
Eszopiclone—Back pain—Doxorubicin—bone cancer	0.00027	0.00111	CcSEcCtD
Eszopiclone—Muscle spasms—Doxorubicin—bone cancer	0.000269	0.0011	CcSEcCtD
Eszopiclone—Palpitations—Epirubicin—bone cancer	0.000267	0.00109	CcSEcCtD
Eszopiclone—Confusional state—Methotrexate—bone cancer	0.000265	0.00109	CcSEcCtD
Eszopiclone—Anaphylactic shock—Methotrexate—bone cancer	0.000263	0.00108	CcSEcCtD
Eszopiclone—Vision blurred—Doxorubicin—bone cancer	0.000263	0.00108	CcSEcCtD
Eszopiclone—Convulsion—Epirubicin—bone cancer	0.000262	0.00107	CcSEcCtD
Eszopiclone—Infection—Methotrexate—bone cancer	0.000262	0.00107	CcSEcCtD
Eszopiclone—Hypertension—Epirubicin—bone cancer	0.000261	0.00107	CcSEcCtD
Eszopiclone—Ill-defined disorder—Doxorubicin—bone cancer	0.000259	0.00106	CcSEcCtD
Eszopiclone—Anaemia—Doxorubicin—bone cancer	0.000258	0.00106	CcSEcCtD
Eszopiclone—Myalgia—Epirubicin—bone cancer	0.000257	0.00105	CcSEcCtD
Eszopiclone—Chest pain—Epirubicin—bone cancer	0.000257	0.00105	CcSEcCtD
Eszopiclone—Agitation—Doxorubicin—bone cancer	0.000257	0.00105	CcSEcCtD
Eszopiclone—Anxiety—Epirubicin—bone cancer	0.000256	0.00105	CcSEcCtD
Eszopiclone—Hyperhidrosis—Methotrexate—bone cancer	0.000254	0.00104	CcSEcCtD
Eszopiclone—Discomfort—Epirubicin—bone cancer	0.000254	0.00104	CcSEcCtD
Eszopiclone—Malaise—Doxorubicin—bone cancer	0.000252	0.00103	CcSEcCtD
Eszopiclone—Dry mouth—Epirubicin—bone cancer	0.000251	0.00103	CcSEcCtD
Eszopiclone—Vertigo—Doxorubicin—bone cancer	0.000251	0.00103	CcSEcCtD
Eszopiclone—Anorexia—Methotrexate—bone cancer	0.000251	0.00103	CcSEcCtD
Eszopiclone—Confusional state—Epirubicin—bone cancer	0.000248	0.00102	CcSEcCtD
Eszopiclone—Palpitations—Doxorubicin—bone cancer	0.000247	0.00101	CcSEcCtD
Eszopiclone—Anaphylactic shock—Epirubicin—bone cancer	0.000246	0.00101	CcSEcCtD
Eszopiclone—Infection—Epirubicin—bone cancer	0.000245	0.001	CcSEcCtD
Eszopiclone—Convulsion—Doxorubicin—bone cancer	0.000242	0.000991	CcSEcCtD
Eszopiclone—Hypertension—Doxorubicin—bone cancer	0.000241	0.000987	CcSEcCtD
Eszopiclone—Tachycardia—Epirubicin—bone cancer	0.00024	0.000984	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Methotrexate—bone cancer	0.00024	0.000982	CcSEcCtD
Eszopiclone—Hyperhidrosis—Epirubicin—bone cancer	0.000238	0.000975	CcSEcCtD
Eszopiclone—Insomnia—Methotrexate—bone cancer	0.000238	0.000975	CcSEcCtD
Eszopiclone—Myalgia—Doxorubicin—bone cancer	0.000238	0.000973	CcSEcCtD
Eszopiclone—Chest pain—Doxorubicin—bone cancer	0.000238	0.000973	CcSEcCtD
Eszopiclone—Anxiety—Doxorubicin—bone cancer	0.000237	0.00097	CcSEcCtD
Eszopiclone—Paraesthesia—Methotrexate—bone cancer	0.000236	0.000968	CcSEcCtD
Eszopiclone—Discomfort—Doxorubicin—bone cancer	0.000235	0.000962	CcSEcCtD
Eszopiclone—Anorexia—Epirubicin—bone cancer	0.000235	0.000961	CcSEcCtD
Eszopiclone—Dyspnoea—Methotrexate—bone cancer	0.000235	0.000961	CcSEcCtD
Eszopiclone—Somnolence—Methotrexate—bone cancer	0.000234	0.000958	CcSEcCtD
Eszopiclone—Dry mouth—Doxorubicin—bone cancer	0.000233	0.000952	CcSEcCtD
Eszopiclone—Dyspepsia—Methotrexate—bone cancer	0.000232	0.000949	CcSEcCtD
Eszopiclone—Confusional state—Doxorubicin—bone cancer	0.00023	0.000941	CcSEcCtD
Eszopiclone—Decreased appetite—Methotrexate—bone cancer	0.000229	0.000937	CcSEcCtD
Eszopiclone—Anaphylactic shock—Doxorubicin—bone cancer	0.000228	0.000933	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Methotrexate—bone cancer	0.000227	0.00093	CcSEcCtD
Eszopiclone—Fatigue—Methotrexate—bone cancer	0.000227	0.000929	CcSEcCtD
Eszopiclone—Infection—Doxorubicin—bone cancer	0.000226	0.000927	CcSEcCtD
Eszopiclone—Pain—Methotrexate—bone cancer	0.000225	0.000921	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000224	0.000919	CcSEcCtD
Eszopiclone—Insomnia—Epirubicin—bone cancer	0.000223	0.000912	CcSEcCtD
Eszopiclone—Tachycardia—Doxorubicin—bone cancer	0.000222	0.000911	CcSEcCtD
Eszopiclone—Paraesthesia—Epirubicin—bone cancer	0.000221	0.000906	CcSEcCtD
Eszopiclone—Hyperhidrosis—Doxorubicin—bone cancer	0.00022	0.000902	CcSEcCtD
Eszopiclone—Dyspnoea—Epirubicin—bone cancer	0.00022	0.000899	CcSEcCtD
Eszopiclone—Somnolence—Epirubicin—bone cancer	0.000219	0.000896	CcSEcCtD
Eszopiclone—Anorexia—Doxorubicin—bone cancer	0.000217	0.000889	CcSEcCtD
Eszopiclone—Feeling abnormal—Methotrexate—bone cancer	0.000217	0.000888	CcSEcCtD
Eszopiclone—Dyspepsia—Epirubicin—bone cancer	0.000217	0.000888	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Methotrexate—bone cancer	0.000215	0.000881	CcSEcCtD
Eszopiclone—Decreased appetite—Epirubicin—bone cancer	0.000214	0.000877	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Epirubicin—bone cancer	0.000213	0.000871	CcSEcCtD
Eszopiclone—Fatigue—Epirubicin—bone cancer	0.000212	0.000869	CcSEcCtD
Eszopiclone—Constipation—Epirubicin—bone cancer	0.000211	0.000862	CcSEcCtD
Eszopiclone—Pain—Epirubicin—bone cancer	0.000211	0.000862	CcSEcCtD
Eszopiclone—Urticaria—Methotrexate—bone cancer	0.000209	0.000856	CcSEcCtD
Eszopiclone—Abdominal pain—Methotrexate—bone cancer	0.000208	0.000852	CcSEcCtD
Eszopiclone—Body temperature increased—Methotrexate—bone cancer	0.000208	0.000852	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000208	0.00085	CcSEcCtD
Eszopiclone—Insomnia—Doxorubicin—bone cancer	0.000206	0.000844	CcSEcCtD
Eszopiclone—Paraesthesia—Doxorubicin—bone cancer	0.000205	0.000838	CcSEcCtD
Eszopiclone—Dyspnoea—Doxorubicin—bone cancer	0.000203	0.000832	CcSEcCtD
Eszopiclone—Feeling abnormal—Epirubicin—bone cancer	0.000203	0.000831	CcSEcCtD
Eszopiclone—Somnolence—Doxorubicin—bone cancer	0.000203	0.00083	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Epirubicin—bone cancer	0.000201	0.000825	CcSEcCtD
Eszopiclone—Dyspepsia—Doxorubicin—bone cancer	0.000201	0.000821	CcSEcCtD
Eszopiclone—Decreased appetite—Doxorubicin—bone cancer	0.000198	0.000811	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000197	0.000806	CcSEcCtD
Eszopiclone—Fatigue—Doxorubicin—bone cancer	0.000197	0.000804	CcSEcCtD
Eszopiclone—Urticaria—Epirubicin—bone cancer	0.000196	0.000801	CcSEcCtD
Eszopiclone—Pain—Doxorubicin—bone cancer	0.000195	0.000798	CcSEcCtD
Eszopiclone—Constipation—Doxorubicin—bone cancer	0.000195	0.000798	CcSEcCtD
Eszopiclone—Abdominal pain—Epirubicin—bone cancer	0.000195	0.000797	CcSEcCtD
Eszopiclone—Body temperature increased—Epirubicin—bone cancer	0.000195	0.000797	CcSEcCtD
Eszopiclone—Hypersensitivity—Methotrexate—bone cancer	0.000194	0.000794	CcSEcCtD
Eszopiclone—Asthenia—Methotrexate—bone cancer	0.000189	0.000773	CcSEcCtD
Eszopiclone—Feeling abnormal—Doxorubicin—bone cancer	0.000188	0.000769	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Doxorubicin—bone cancer	0.000186	0.000763	CcSEcCtD
Eszopiclone—Pruritus—Methotrexate—bone cancer	0.000186	0.000762	CcSEcCtD
Eszopiclone—Hypersensitivity—Epirubicin—bone cancer	0.000182	0.000743	CcSEcCtD
Eszopiclone—Urticaria—Doxorubicin—bone cancer	0.000181	0.000741	CcSEcCtD
Eszopiclone—Body temperature increased—Doxorubicin—bone cancer	0.00018	0.000738	CcSEcCtD
Eszopiclone—Abdominal pain—Doxorubicin—bone cancer	0.00018	0.000738	CcSEcCtD
Eszopiclone—Diarrhoea—Methotrexate—bone cancer	0.00018	0.000737	CcSEcCtD
Eszopiclone—Asthenia—Epirubicin—bone cancer	0.000177	0.000724	CcSEcCtD
Eszopiclone—Pruritus—Epirubicin—bone cancer	0.000174	0.000713	CcSEcCtD
Eszopiclone—Dizziness—Methotrexate—bone cancer	0.000174	0.000713	CcSEcCtD
Eszopiclone—Diarrhoea—Epirubicin—bone cancer	0.000169	0.00069	CcSEcCtD
Eszopiclone—Hypersensitivity—Doxorubicin—bone cancer	0.000168	0.000687	CcSEcCtD
Eszopiclone—Vomiting—Methotrexate—bone cancer	0.000167	0.000685	CcSEcCtD
Eszopiclone—Rash—Methotrexate—bone cancer	0.000166	0.000679	CcSEcCtD
Eszopiclone—Dermatitis—Methotrexate—bone cancer	0.000166	0.000679	CcSEcCtD
Eszopiclone—Headache—Methotrexate—bone cancer	0.000165	0.000675	CcSEcCtD
Eszopiclone—Asthenia—Doxorubicin—bone cancer	0.000164	0.000669	CcSEcCtD
Eszopiclone—Dizziness—Epirubicin—bone cancer	0.000163	0.000667	CcSEcCtD
Eszopiclone—Pruritus—Doxorubicin—bone cancer	0.000161	0.00066	CcSEcCtD
Eszopiclone—Vomiting—Epirubicin—bone cancer	0.000157	0.000641	CcSEcCtD
Eszopiclone—Nausea—Methotrexate—bone cancer	0.000156	0.00064	CcSEcCtD
Eszopiclone—Diarrhoea—Doxorubicin—bone cancer	0.000156	0.000638	CcSEcCtD
Eszopiclone—Rash—Epirubicin—bone cancer	0.000155	0.000636	CcSEcCtD
Eszopiclone—Dermatitis—Epirubicin—bone cancer	0.000155	0.000635	CcSEcCtD
Eszopiclone—Headache—Epirubicin—bone cancer	0.000154	0.000632	CcSEcCtD
Eszopiclone—Dizziness—Doxorubicin—bone cancer	0.000151	0.000617	CcSEcCtD
Eszopiclone—Nausea—Epirubicin—bone cancer	0.000146	0.000599	CcSEcCtD
Eszopiclone—Vomiting—Doxorubicin—bone cancer	0.000145	0.000593	CcSEcCtD
Eszopiclone—Rash—Doxorubicin—bone cancer	0.000144	0.000588	CcSEcCtD
Eszopiclone—Dermatitis—Doxorubicin—bone cancer	0.000144	0.000588	CcSEcCtD
Eszopiclone—Headache—Doxorubicin—bone cancer	0.000143	0.000585	CcSEcCtD
Eszopiclone—Nausea—Doxorubicin—bone cancer	0.000135	0.000554	CcSEcCtD
Eszopiclone—CYP2C8—Oxidation by Cytochrome P450—CYP4V2—bone cancer	2.53e-07	0.0345	CbGpPWpGaD
Eszopiclone—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	2.42e-07	0.033	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—FEV—bone cancer	2.08e-07	0.0283	CbGpPWpGaD
Eszopiclone—CYP2C9—Oxidation by Cytochrome P450—CYP4V2—bone cancer	2.06e-07	0.0281	CbGpPWpGaD
Eszopiclone—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	1.97e-07	0.0268	CbGpPWpGaD
Eszopiclone—GABRG3—Orphan transporters—TUBB4B—bone cancer	1.77e-07	0.0241	CbGpPWpGaD
Eszopiclone—GABRA4—Orphan transporters—TUBB4B—bone cancer	1.63e-07	0.0222	CbGpPWpGaD
Eszopiclone—GABRG3—Orphan transporters—TUBB2A—bone cancer	1.53e-07	0.0208	CbGpPWpGaD
Eszopiclone—GABRB2—Orphan transporters—TUBB4B—bone cancer	1.49e-07	0.0203	CbGpPWpGaD
Eszopiclone—GABRA5—Orphan transporters—TUBB4B—bone cancer	1.45e-07	0.0197	CbGpPWpGaD
Eszopiclone—GABRA3—Orphan transporters—TUBB4B—bone cancer	1.42e-07	0.0194	CbGpPWpGaD
Eszopiclone—GABRA4—Orphan transporters—TUBB2A—bone cancer	1.41e-07	0.0192	CbGpPWpGaD
Eszopiclone—GABRA2—Orphan transporters—TUBB4B—bone cancer	1.4e-07	0.019	CbGpPWpGaD
Eszopiclone—GABRG2—Orphan transporters—TUBB4B—bone cancer	1.37e-07	0.0186	CbGpPWpGaD
Eszopiclone—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	1.36e-07	0.0185	CbGpPWpGaD
Eszopiclone—GABRB2—Orphan transporters—TUBB2A—bone cancer	1.29e-07	0.0175	CbGpPWpGaD
Eszopiclone—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	1.28e-07	0.0174	CbGpPWpGaD
Eszopiclone—GABRA5—Orphan transporters—TUBB2A—bone cancer	1.25e-07	0.017	CbGpPWpGaD
Eszopiclone—GABRA3—Orphan transporters—TUBB2A—bone cancer	1.23e-07	0.0167	CbGpPWpGaD
Eszopiclone—CYP2C8—Xenobiotics—CYP3A4—bone cancer	1.22e-07	0.0166	CbGpPWpGaD
Eszopiclone—GABRA2—Orphan transporters—TUBB2A—bone cancer	1.21e-07	0.0164	CbGpPWpGaD
Eszopiclone—GABRA1—Orphan transporters—TUBB4B—bone cancer	1.19e-07	0.0162	CbGpPWpGaD
Eszopiclone—GABRG2—Orphan transporters—TUBB2A—bone cancer	1.18e-07	0.016	CbGpPWpGaD
Eszopiclone—CYP2C8—Tamoxifen metabolism—CYP3A4—bone cancer	1.18e-07	0.016	CbGpPWpGaD
Eszopiclone—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—bone cancer	1.12e-07	0.0152	CbGpPWpGaD
Eszopiclone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	1.11e-07	0.0152	CbGpPWpGaD
Eszopiclone—CYP2C8—Metapathway biotransformation—CYP4V2—bone cancer	1.09e-07	0.0148	CbGpPWpGaD
Eszopiclone—GABRA1—Orphan transporters—TUBB2A—bone cancer	1.03e-07	0.014	CbGpPWpGaD
Eszopiclone—CYP2C9—Xenobiotics—CYP3A4—bone cancer	9.96e-08	0.0135	CbGpPWpGaD
Eszopiclone—CYP2C9—Tamoxifen metabolism—CYP3A4—bone cancer	9.57e-08	0.013	CbGpPWpGaD
Eszopiclone—CYP2C9—Metapathway biotransformation—CYP4V2—bone cancer	8.88e-08	0.0121	CbGpPWpGaD
Eszopiclone—PTGS1—Overview of nanoparticle effects—PTGS2—bone cancer	8.74e-08	0.0119	CbGpPWpGaD
Eszopiclone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	7.35e-08	0.01	CbGpPWpGaD
Eszopiclone—PTGS1—Eicosanoid Synthesis—PTGS2—bone cancer	7.25e-08	0.00986	CbGpPWpGaD
Eszopiclone—CYP2C9—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	6.84e-08	0.0093	CbGpPWpGaD
Eszopiclone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	6.51e-08	0.00886	CbGpPWpGaD
Eszopiclone—PTGS1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	6.38e-08	0.00867	CbGpPWpGaD
Eszopiclone—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—bone cancer	6.07e-08	0.00825	CbGpPWpGaD
Eszopiclone—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	5.86e-08	0.00796	CbGpPWpGaD
Eszopiclone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	5.08e-08	0.00691	CbGpPWpGaD
Eszopiclone—CYP2C8—Oxidation by Cytochrome P450—CYP3A4—bone cancer	5.01e-08	0.00682	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—TUBB4B—bone cancer	4.33e-08	0.00589	CbGpPWpGaD
Eszopiclone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	4.13e-08	0.00562	CbGpPWpGaD
Eszopiclone—CYP2C8—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	4.12e-08	0.0056	CbGpPWpGaD
Eszopiclone—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—bone cancer	4.08e-08	0.00555	CbGpPWpGaD
Eszopiclone—PTGS1—Arachidonic acid metabolism—PTGS2—bone cancer	4.03e-08	0.00548	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—TUBB4B—bone cancer	3.98e-08	0.00542	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—TUBB2A—bone cancer	3.74e-08	0.00508	CbGpPWpGaD
Eszopiclone—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	3.65e-08	0.00497	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—TUBB4B—bone cancer	3.64e-08	0.00496	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—TUBB4B—bone cancer	3.54e-08	0.00481	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—TUBB4B—bone cancer	3.48e-08	0.00473	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—TUBB2A—bone cancer	3.44e-08	0.00468	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—TUBB4B—bone cancer	3.42e-08	0.00465	CbGpPWpGaD
Eszopiclone—PTGS1—Biological oxidations—CYP3A4—bone cancer	3.39e-08	0.00461	CbGpPWpGaD
Eszopiclone—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	3.36e-08	0.00457	CbGpPWpGaD
Eszopiclone—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	3.35e-08	0.00456	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—TUBB4B—bone cancer	3.33e-08	0.00453	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—TUBB2A—bone cancer	3.15e-08	0.00428	CbGpPWpGaD
Eszopiclone—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	3.07e-08	0.00418	CbGpPWpGaD
Eszopiclone—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	3.06e-08	0.00416	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—TUBB2A—bone cancer	3.06e-08	0.00416	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—TUBB2A—bone cancer	3e-08	0.00408	CbGpPWpGaD
Eszopiclone—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	2.99e-08	0.00406	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—TUBB2A—bone cancer	2.95e-08	0.00401	CbGpPWpGaD
Eszopiclone—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	2.93e-08	0.00399	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—TUBB4B—bone cancer	2.91e-08	0.00396	CbGpPWpGaD
Eszopiclone—PTGS1—Biological oxidations—GSTP1—bone cancer	2.9e-08	0.00394	CbGpPWpGaD
Eszopiclone—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	2.88e-08	0.00392	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—TUBB2A—bone cancer	2.88e-08	0.00391	CbGpPWpGaD
Eszopiclone—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	2.82e-08	0.00383	CbGpPWpGaD
Eszopiclone—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	2.81e-08	0.00382	CbGpPWpGaD
Eszopiclone—GABRG3—Transmission across Chemical Synapses—BRAF—bone cancer	2.75e-08	0.00373	CbGpPWpGaD
Eszopiclone—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	2.6e-08	0.00354	CbGpPWpGaD
Eszopiclone—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	2.58e-08	0.0035	CbGpPWpGaD
Eszopiclone—PTGS1—Selenium Micronutrient Network—PTGS2—bone cancer	2.56e-08	0.00349	CbGpPWpGaD
Eszopiclone—GABRA4—Transmission across Chemical Synapses—BRAF—bone cancer	2.53e-08	0.00344	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—TUBB2A—bone cancer	2.51e-08	0.00342	CbGpPWpGaD
Eszopiclone—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	2.5e-08	0.0034	CbGpPWpGaD
Eszopiclone—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	2.46e-08	0.00334	CbGpPWpGaD
Eszopiclone—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	2.46e-08	0.00334	CbGpPWpGaD
Eszopiclone—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	2.41e-08	0.00328	CbGpPWpGaD
Eszopiclone—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	2.36e-08	0.0032	CbGpPWpGaD
Eszopiclone—GABRB2—Transmission across Chemical Synapses—BRAF—bone cancer	2.31e-08	0.00314	CbGpPWpGaD
Eszopiclone—GABRG3—Transmission across Chemical Synapses—MDM2—bone cancer	2.3e-08	0.00313	CbGpPWpGaD
Eszopiclone—GABRA5—Transmission across Chemical Synapses—BRAF—bone cancer	2.24e-08	0.00305	CbGpPWpGaD
Eszopiclone—GABRA3—Transmission across Chemical Synapses—BRAF—bone cancer	2.2e-08	0.003	CbGpPWpGaD
Eszopiclone—CYP2C8—Biological oxidations—CYP3A4—bone cancer	2.19e-08	0.00298	CbGpPWpGaD
Eszopiclone—GABRA2—Transmission across Chemical Synapses—BRAF—bone cancer	2.17e-08	0.00295	CbGpPWpGaD
Eszopiclone—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	2.16e-08	0.00293	CbGpPWpGaD
Eszopiclone—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	2.12e-08	0.00288	CbGpPWpGaD
Eszopiclone—GABRA4—Transmission across Chemical Synapses—MDM2—bone cancer	2.12e-08	0.00288	CbGpPWpGaD
Eszopiclone—GABRG2—Transmission across Chemical Synapses—BRAF—bone cancer	2.11e-08	0.00287	CbGpPWpGaD
Eszopiclone—GABRG3—Neuronal System—BRAF—bone cancer	2.1e-08	0.00286	CbGpPWpGaD
Eszopiclone—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	2.06e-08	0.0028	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—NDUFA12—bone cancer	2.03e-08	0.00276	CbGpPWpGaD
Eszopiclone—GABRB2—Transmission across Chemical Synapses—MDM2—bone cancer	1.94e-08	0.00263	CbGpPWpGaD
Eszopiclone—GABRA4—Neuronal System—BRAF—bone cancer	1.94e-08	0.00263	CbGpPWpGaD
Eszopiclone—GABRA5—Transmission across Chemical Synapses—MDM2—bone cancer	1.88e-08	0.00256	CbGpPWpGaD
Eszopiclone—CYP2C8—Biological oxidations—GSTP1—bone cancer	1.87e-08	0.00254	CbGpPWpGaD
Eszopiclone—GABRA1—Transmission across Chemical Synapses—BRAF—bone cancer	1.85e-08	0.00251	CbGpPWpGaD
Eszopiclone—GABRA3—Transmission across Chemical Synapses—MDM2—bone cancer	1.85e-08	0.00251	CbGpPWpGaD
Eszopiclone—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	1.85e-08	0.00251	CbGpPWpGaD
Eszopiclone—GABRA2—Transmission across Chemical Synapses—MDM2—bone cancer	1.82e-08	0.00247	CbGpPWpGaD
Eszopiclone—CYP2C9—Biological oxidations—CYP3A4—bone cancer	1.78e-08	0.00242	CbGpPWpGaD
Eszopiclone—GABRG2—Transmission across Chemical Synapses—MDM2—bone cancer	1.77e-08	0.00241	CbGpPWpGaD
Eszopiclone—GABRB2—Neuronal System—BRAF—bone cancer	1.77e-08	0.00241	CbGpPWpGaD
Eszopiclone—GABRG3—Neuronal System—MDM2—bone cancer	1.76e-08	0.0024	CbGpPWpGaD
Eszopiclone—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	1.76e-08	0.00239	CbGpPWpGaD
Eszopiclone—GABRA5—Neuronal System—BRAF—bone cancer	1.72e-08	0.00234	CbGpPWpGaD
Eszopiclone—GABRA3—Neuronal System—BRAF—bone cancer	1.69e-08	0.0023	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—NT5C3A—bone cancer	1.68e-08	0.00229	CbGpPWpGaD
Eszopiclone—GABRA2—Neuronal System—BRAF—bone cancer	1.66e-08	0.00226	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—JUN—bone cancer	1.64e-08	0.00223	CbGpPWpGaD
Eszopiclone—GABRA4—Neuronal System—MDM2—bone cancer	1.62e-08	0.00221	CbGpPWpGaD
Eszopiclone—GABRG2—Neuronal System—BRAF—bone cancer	1.62e-08	0.0022	CbGpPWpGaD
Eszopiclone—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	1.55e-08	0.00211	CbGpPWpGaD
Eszopiclone—GABRA1—Transmission across Chemical Synapses—MDM2—bone cancer	1.55e-08	0.00211	CbGpPWpGaD
Eszopiclone—CYP2C9—Biological oxidations—GSTP1—bone cancer	1.52e-08	0.00207	CbGpPWpGaD
Eszopiclone—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	1.5e-08	0.00204	CbGpPWpGaD
Eszopiclone—GABRB2—Neuronal System—MDM2—bone cancer	1.48e-08	0.00202	CbGpPWpGaD
Eszopiclone—GABRA5—Neuronal System—MDM2—bone cancer	1.44e-08	0.00196	CbGpPWpGaD
Eszopiclone—GABRA1—Neuronal System—BRAF—bone cancer	1.42e-08	0.00193	CbGpPWpGaD
Eszopiclone—GABRA3—Neuronal System—MDM2—bone cancer	1.42e-08	0.00192	CbGpPWpGaD
Eszopiclone—GABRA2—Neuronal System—MDM2—bone cancer	1.39e-08	0.00189	CbGpPWpGaD
Eszopiclone—GABRG2—Neuronal System—MDM2—bone cancer	1.36e-08	0.00185	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—NDUFA12—bone cancer	1.31e-08	0.00178	CbGpPWpGaD
Eszopiclone—GABRA1—Neuronal System—MDM2—bone cancer	1.19e-08	0.00161	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—NT5C3A—bone cancer	1.09e-08	0.00148	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—NDUFA12—bone cancer	1.07e-08	0.00145	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—GSTP1—bone cancer	1e-08	0.00137	CbGpPWpGaD
Eszopiclone—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	9.9e-09	0.00135	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—NT5C3A—bone cancer	8.84e-09	0.0012	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—ENO2—bone cancer	7.37e-09	0.001	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—NDUFA12—bone cancer	7.04e-09	0.000957	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—DHFR—bone cancer	6.83e-09	0.00093	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GNA11—bone cancer	6.39e-09	0.000869	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—NT5C3A—bone cancer	5.83e-09	0.000793	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—CYP3A4—bone cancer	5.79e-09	0.000788	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	5.76e-09	0.000784	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GSTP1—bone cancer	4.95e-09	0.000674	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—ENO2—bone cancer	4.76e-09	0.000647	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—DHFR—bone cancer	4.41e-09	0.000601	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GNA11—bone cancer	4.13e-09	0.000561	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—ENO2—bone cancer	3.87e-09	0.000527	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CYP3A4—bone cancer	3.74e-09	0.000509	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.72e-09	0.000506	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—DHFR—bone cancer	3.59e-09	0.000489	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GNA11—bone cancer	3.36e-09	0.000457	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GSTP1—bone cancer	3.2e-09	0.000435	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CYP3A4—bone cancer	3.04e-09	0.000414	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.03e-09	0.000412	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GSTP1—bone cancer	2.6e-09	0.000354	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PTGS2—bone cancer	2.57e-09	0.000349	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ENO2—bone cancer	2.55e-09	0.000347	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—DHFR—bone cancer	2.37e-09	0.000322	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GNA11—bone cancer	2.21e-09	0.000301	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GSTP1—bone cancer	1.72e-09	0.000234	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PTGS2—bone cancer	1.66e-09	0.000225	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PTGS2—bone cancer	1.35e-09	0.000183	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PTGS2—bone cancer	8.9e-10	0.000121	CbGpPWpGaD
